Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 16/20 | 0.69 |
| ▸ | NPY1R | P25929 | 10/20 | 0.69 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.69 |
| ▸ | NPY2R | P49146 | 6/20 | 0.69 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31680260 | 1.00 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30974010 | 0.98 | NPY4R (0.72) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL31680264 | 0.93 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL31410875 | 0.93 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL31345750 | 0.93 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29493332 | 0.92 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30669459 | 0.90 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29732346 | 0.90 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30213828 | 0.89 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2ROPRD1 | |
| SCHEMBL29574373 | 0.89 | NPY4R (0.71) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024132726-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |